Author:
Babic N.,Garner K.S.,Hirschhorn J.W.,Zebian R.,Nolte F.S.
Subject
Clinical Biochemistry,General Medicine
Reference21 articles.
1. U.S. Food and Drug Administration, In Vitro Diagnostics EUAs. https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/vitro-diagnostics-euas#individual-molecular (accessed 30 August 2021).
2. South Carolina County-Level Data for COVID-19. https://scdhec.gov/covid19/covid-19-data/south-carolina-county-level-data-covid-19 (accessed 15 October 2021).
3. Comparison of Abbott ID NOW and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients;Harrington;J. Clin. Microbiol.,2020
4. Evaluation of the COVID19 ID NOW EUA assay;Mitchell;J. Clin. Virol.,2020
5. Comparison of Abbott ID NOW, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19;Rhoads;J. Clin. Microbiol.,2020
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献